Innovation Unleashed: REPROCELL's Q1 Recap and Insights
13 July 2023
As REPROCELL emerges from the first quarter of 2023-24, we are thrilled to present a snapshot of the activities and achievements that have set the stage for a productive year. From the launch of our new Pharmacology-AI service to winning a ...
End of Q4 update from REPROCELL (2022-23)
04 May 2023
Did you know that REPROCELL is celebrating its 20th anniversary this year? If you missed the commemorative letter from our CEO we have included a link below - plus everything else we’ve been up to since the start of 2023. Celebrating the 20...
Celebrating the 20th Anniversary of REPROCELL: A letter from our CEO Chikafumi Yokoyama
28 February 2023
On February 26, 2023, REPROCELL celebrated its 20th anniversary. I would like to express our sincere gratitude to our customers who use our products and services, our shareholders who have invested in us with high expectations for our futur...
End of Q3 update from REPROCELL (2022-23)
12 December 2022
The year might be coming to a close, but we’re not winding down at REPROCELL. The final months of 2022 have brought new collaborations, partnerships, and successes to enrich your stem cell and drug discovery research. This includes our memb...
End of Q2 update from REPROCELL (2022-23)
03 October 2022
We're halfway through the financial year and there are only three months left in 2022. Time is racing but REPROCELL has managed to pack in a lot since our last update, including three conferences and the launch of our clinical laboratory se...
REPROCELL will participate at the Biotechgate Digital Partnering Event.
21 April 2021
REPROCELL USA and REPROCELL Europe will be attending all 5 days of the Biotechgate Digital Partnering 2021 Event, 3-7 May 2021. Partnering scheduling is now open, and registration is free. Have a one-on-one Zoom meeting with our experts and...
REPROCELL Becomes VIP Supplier on Scientist.com Biotech Marketplace
10 December 2020
Beltsville, USA: REPROCELL, an industry leader in the use of human biospecimens for medical research, has partnered with Scientist.com, the healthcare industry’s leading marketplace for life science research, to bring its services to the gl...
Appointment of New Distributor in Thailand
04 November 2019
The REPROCELL group has signed a non-exclusive distributorship agreement with A.N.H. Scientific Marketing Co. Ltd. to distribute REPROCELL’s products and services in Thailand. For more than 35 years, A.N.H. Scientific Marketing Co. Ltd. has...
PRESS RELEASE: Axion BioSystems make REPROCELL a product distributor
28 August 2019
Axion BioSystems, Inc., the world leader in multi-well microelectrode array (MEA) systems, has announced REPROCELL as the new distributor of its Maestro systems and consumables in Japan. Maestro Pro and Maestro Edge are the world’s most adv...
Appointment of New Distributor in China
01 February 2019
The REPROCELL group has signed a non-exclusive distributorship agreement with RUITAI Biotechnology (Shanghai) Ltd to distribute REPROCELL’s products in China. Through the RUITAI group’s offices in Shanghai, Hangzhou, and Shenyang, and combi...